

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | triglyceride catabolic process (GO:0019433) | 8.23171160 |
| 2 | alpha-linolenic acid metabolic process (GO:0036109) | 6.18027242 |
| 3 | diacylglycerol metabolic process (GO:0046339) | 6.06949003 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 6.04268148 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.04268148 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 5.77152331 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.77152331 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.57557774 |
| 9 | glycerolipid catabolic process (GO:0046503) | 5.52186529 |
| 10 | aromatic amino acid family catabolic process (GO:0009074) | 5.29610339 |
| 11 | * fatty acid homeostasis (GO:0055089) | 5.08674204 |
| 12 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.94692509 |
| 13 | ethanol metabolic process (GO:0006067) | 4.93539689 |
| 14 | glyoxylate metabolic process (GO:0046487) | 4.91720739 |
| 15 | kynurenine metabolic process (GO:0070189) | 4.91413760 |
| 16 | lysine metabolic process (GO:0006553) | 4.86878700 |
| 17 | lysine catabolic process (GO:0006554) | 4.86878700 |
| 18 | bile acid biosynthetic process (GO:0006699) | 4.86721721 |
| 19 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.80639331 |
| 20 | NADH metabolic process (GO:0006734) | 4.80127286 |
| 21 | * triglyceride biosynthetic process (GO:0019432) | 4.79026879 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 4.78155846 |
| 23 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.76378899 |
| 24 | tryptophan catabolic process (GO:0006569) | 4.68364580 |
| 25 | indole-containing compound catabolic process (GO:0042436) | 4.68364580 |
| 26 | indolalkylamine catabolic process (GO:0046218) | 4.68364580 |
| 27 | regulation of cholesterol storage (GO:0010885) | 4.68178637 |
| 28 | regulation of triglyceride catabolic process (GO:0010896) | 4.66114720 |
| 29 | brown fat cell differentiation (GO:0050873) | 4.65289159 |
| 30 | complement activation, alternative pathway (GO:0006957) | 4.64937835 |
| 31 | * neutral lipid biosynthetic process (GO:0046460) | 4.63675391 |
| 32 | * acylglycerol biosynthetic process (GO:0046463) | 4.63675391 |
| 33 | cysteine metabolic process (GO:0006534) | 4.61914345 |
| 34 | lipid storage (GO:0019915) | 4.59736721 |
| 35 | urea metabolic process (GO:0019627) | 4.59517931 |
| 36 | urea cycle (GO:0000050) | 4.59517931 |
| 37 | * triglyceride metabolic process (GO:0006641) | 4.55653139 |
| 38 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.52829174 |
| 39 | high-density lipoprotein particle remodeling (GO:0034375) | 4.45385233 |
| 40 | acetyl-CoA metabolic process (GO:0006084) | 4.45180032 |
| 41 | tryptophan metabolic process (GO:0006568) | 4.43435394 |
| 42 | negative regulation of fibrinolysis (GO:0051918) | 4.41531411 |
| 43 | amino-acid betaine metabolic process (GO:0006577) | 4.41307893 |
| 44 | regulation of protein activation cascade (GO:2000257) | 4.40848145 |
| 45 | primary alcohol metabolic process (GO:0034308) | 4.39871172 |
| 46 | fatty acid transmembrane transport (GO:1902001) | 4.37327942 |
| 47 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.36590076 |
| 48 | serine family amino acid catabolic process (GO:0009071) | 4.32190959 |
| 49 | fatty acid beta-oxidation (GO:0006635) | 4.31619895 |
| 50 | oxaloacetate metabolic process (GO:0006107) | 4.30944227 |
| 51 | ethanol oxidation (GO:0006069) | 4.28937828 |
| 52 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.28592514 |
| 53 | protein carboxylation (GO:0018214) | 4.28592514 |
| 54 | plasma lipoprotein particle clearance (GO:0034381) | 4.26380616 |
| 55 | * acylglycerol metabolic process (GO:0006639) | 4.25379353 |
| 56 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 4.23833801 |
| 57 | cellular ketone body metabolic process (GO:0046950) | 4.21972297 |
| 58 | 2-oxoglutarate metabolic process (GO:0006103) | 4.21779942 |
| 59 | bile acid metabolic process (GO:0008206) | 4.21600581 |
| 60 | nitrogen cycle metabolic process (GO:0071941) | 4.21102003 |
| 61 | positive regulation of lipid storage (GO:0010884) | 4.19872130 |
| 62 | * neutral lipid metabolic process (GO:0006638) | 4.18982897 |
| 63 | reverse cholesterol transport (GO:0043691) | 4.17636030 |
| 64 | homocysteine metabolic process (GO:0050667) | 4.17366867 |
| 65 | tricarboxylic acid metabolic process (GO:0072350) | 4.17003405 |
| 66 | regulation of complement activation (GO:0030449) | 4.16308223 |
| 67 | regulation of fibrinolysis (GO:0051917) | 4.15315014 |
| 68 | acylglycerol homeostasis (GO:0055090) | 4.15107430 |
| 69 | triglyceride homeostasis (GO:0070328) | 4.15107430 |
| 70 | short-chain fatty acid metabolic process (GO:0046459) | 4.13648773 |
| 71 | lipid particle organization (GO:0034389) | 4.10548609 |
| 72 | carnitine shuttle (GO:0006853) | 4.07739627 |
| 73 | response to phenylpropanoid (GO:0080184) | 4.07337859 |
| 74 | fatty acid oxidation (GO:0019395) | 4.07053004 |
| 75 | white fat cell differentiation (GO:0050872) | 4.06678678 |
| 76 | alpha-amino acid catabolic process (GO:1901606) | 4.05596327 |
| 77 | valine metabolic process (GO:0006573) | 4.05116364 |
| 78 | positive regulation of lipid catabolic process (GO:0050996) | 4.03056843 |
| 79 | lipid oxidation (GO:0034440) | 4.01680209 |
| 80 | protein-lipid complex remodeling (GO:0034368) | 4.01394472 |
| 81 | macromolecular complex remodeling (GO:0034367) | 4.01394472 |
| 82 | plasma lipoprotein particle remodeling (GO:0034369) | 4.01394472 |
| 83 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.98683104 |
| 84 | fatty acid catabolic process (GO:0009062) | 3.96698792 |
| 85 | positive regulation of fatty acid oxidation (GO:0046321) | 3.96130623 |
| 86 | * acyl-CoA metabolic process (GO:0006637) | 3.94224809 |
| 87 | * thioester metabolic process (GO:0035383) | 3.94224809 |
| 88 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.91145526 |
| 89 | positive regulation of cholesterol efflux (GO:0010875) | 3.90915136 |
| 90 | biotin metabolic process (GO:0006768) | 3.90805008 |
| 91 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.90599924 |
| 92 | regulation of cholesterol esterification (GO:0010872) | 3.89189902 |
| 93 | glycerol metabolic process (GO:0006071) | 3.86703889 |
| 94 | tyrosine metabolic process (GO:0006570) | 3.85165273 |
| 95 | cellular amino acid catabolic process (GO:0009063) | 3.84055628 |
| 96 | monocarboxylic acid catabolic process (GO:0072329) | 3.83580325 |
| 97 | daunorubicin metabolic process (GO:0044597) | 3.83577849 |
| 98 | polyketide metabolic process (GO:0030638) | 3.83577849 |
| 99 | doxorubicin metabolic process (GO:0044598) | 3.83577849 |
| 100 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.82239424 |
| 101 | phospholipid efflux (GO:0033700) | 3.80960411 |
| 102 | aromatic amino acid family metabolic process (GO:0009072) | 3.78753453 |
| 103 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.77543752 |
| 104 | aspartate family amino acid catabolic process (GO:0009068) | 3.77321067 |
| 105 | cellular modified amino acid catabolic process (GO:0042219) | 3.76223801 |
| 106 | glutamate metabolic process (GO:0006536) | 3.76210089 |
| 107 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.74501658 |
| 108 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.74501658 |
| 109 | response to dietary excess (GO:0002021) | 3.72700308 |
| 110 | regulation of sequestering of triglyceride (GO:0010889) | 3.71252223 |
| 111 | coenzyme catabolic process (GO:0009109) | 3.71208622 |
| 112 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.67070016 |
| 113 | ketone body metabolic process (GO:1902224) | 3.66986226 |
| 114 | negative regulation of sterol transport (GO:0032372) | 3.66541737 |
| 115 | negative regulation of cholesterol transport (GO:0032375) | 3.66541737 |
| 116 | regulation of cholesterol homeostasis (GO:2000188) | 3.65431297 |
| 117 | carnitine metabolic process (GO:0009437) | 3.64143444 |
| 118 | retinol metabolic process (GO:0042572) | 3.63508306 |
| 119 | positive regulation of cholesterol transport (GO:0032376) | 3.63112548 |
| 120 | positive regulation of sterol transport (GO:0032373) | 3.63112548 |
| 121 | organic acid catabolic process (GO:0016054) | 3.61604430 |
| 122 | carboxylic acid catabolic process (GO:0046395) | 3.61604430 |
| 123 | low-density lipoprotein particle clearance (GO:0034383) | 3.56271836 |
| 124 | linoleic acid metabolic process (GO:0043651) | 3.56040241 |
| 125 | plasma lipoprotein particle assembly (GO:0034377) | 3.53612572 |
| 126 | alditol metabolic process (GO:0019400) | 3.53210926 |
| 127 | positive regulation of glycolytic process (GO:0045821) | 3.51647817 |
| 128 | cholesterol efflux (GO:0033344) | 3.51173770 |
| 129 | branched-chain amino acid catabolic process (GO:0009083) | 3.50826483 |
| 130 | regulation of triglyceride metabolic process (GO:0090207) | 3.50167967 |
| 131 | regulation of fatty acid oxidation (GO:0046320) | 3.47502020 |
| 132 | glycine metabolic process (GO:0006544) | 3.45427390 |
| 133 | acyl-CoA biosynthetic process (GO:0071616) | 3.45387776 |
| 134 | thioester biosynthetic process (GO:0035384) | 3.45387776 |
| 135 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.45189643 |
| 136 | low-density lipoprotein particle remodeling (GO:0034374) | 3.44171935 |
| 137 | negative regulation of lipase activity (GO:0060192) | 3.43670021 |
| 138 | bile acid and bile salt transport (GO:0015721) | 3.41306122 |
| 139 | regulation of cholesterol metabolic process (GO:0090181) | 3.40876681 |
| 140 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.38834670 |
| 141 | serine family amino acid metabolic process (GO:0009069) | 3.38220222 |
| 142 | acylglycerol catabolic process (GO:0046464) | 3.37757167 |
| 143 | neutral lipid catabolic process (GO:0046461) | 3.37757167 |
| 144 | regulation of sterol transport (GO:0032371) | 3.36706690 |
| 145 | regulation of cholesterol transport (GO:0032374) | 3.36706690 |
| 146 | protein heterotrimerization (GO:0070208) | 3.36488039 |
| 147 | branched-chain amino acid metabolic process (GO:0009081) | 3.35855006 |
| 148 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.34806345 |
| 149 | cellular glucuronidation (GO:0052695) | 3.34222159 |
| 150 | benzene-containing compound metabolic process (GO:0042537) | 3.33771383 |
| 151 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.33076392 |
| 152 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.31873037 |
| 153 | primary alcohol catabolic process (GO:0034310) | 3.30437487 |
| 154 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.30010858 |
| 155 | polyol transport (GO:0015791) | 3.22766813 |
| 156 | transcytosis (GO:0045056) | 3.20880628 |
| 157 | L-serine transport (GO:0015825) | 3.18923259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.68841393 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.96139396 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.94641980 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.02767474 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.65464440 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.97329007 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.49403885 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.90493385 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.43520510 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.11659756 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.54789835 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.49120223 |
| 13 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.88738661 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.80400146 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 1.62777446 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.59670509 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.50745676 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.50429587 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.48599027 |
| 20 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.48217484 |
| 21 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.39961041 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.39008674 |
| 23 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.30652300 |
| 24 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.29198326 |
| 25 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29089638 |
| 26 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.27868070 |
| 27 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.26485747 |
| 28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.25344448 |
| 29 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.24040181 |
| 30 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.16858529 |
| 31 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.13315024 |
| 32 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.13315024 |
| 33 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12230181 |
| 34 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.11437209 |
| 35 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09398339 |
| 36 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.06521400 |
| 37 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06012004 |
| 38 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.05606230 |
| 39 | CJUN_26792858_Chip-Seq_BT549_Human | 1.04743563 |
| 40 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99833831 |
| 41 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98504076 |
| 42 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.98001571 |
| 43 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.95886136 |
| 44 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.94343428 |
| 45 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92619923 |
| 46 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.91598399 |
| 47 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90975827 |
| 48 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.90140347 |
| 49 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.88556752 |
| 50 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.87675115 |
| 51 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.87541501 |
| 52 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85600693 |
| 53 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85600693 |
| 54 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.85128039 |
| 55 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.84650102 |
| 56 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.83651207 |
| 57 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.82856790 |
| 58 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.82143780 |
| 59 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.81604652 |
| 60 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.81291705 |
| 61 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.81291705 |
| 62 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.81264273 |
| 63 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.81073544 |
| 64 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.80536804 |
| 65 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.79851013 |
| 66 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.79763602 |
| 67 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.79369563 |
| 68 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79214409 |
| 69 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78626837 |
| 70 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.77172179 |
| 71 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.75695722 |
| 72 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.75521767 |
| 73 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.75375257 |
| 74 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.75274011 |
| 75 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.75180289 |
| 76 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.74806188 |
| 77 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.74242293 |
| 78 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.73636100 |
| 79 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.72351419 |
| 80 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.71998916 |
| 81 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71384879 |
| 82 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.71052966 |
| 83 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.69442480 |
| 84 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.69032993 |
| 85 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.68933859 |
| 86 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.68185355 |
| 87 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.67568736 |
| 88 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.66507676 |
| 89 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.66018032 |
| 90 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.65709332 |
| 91 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.65678603 |
| 92 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.65063959 |
| 93 | GATA2_19941826_ChIP-Seq_K562_Human | 0.64960459 |
| 94 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.62181879 |
| 95 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.61447489 |
| 96 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.60744513 |
| 97 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.60650091 |
| 98 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.60596653 |
| 99 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.60586481 |
| 100 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.59558797 |
| 101 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.58531726 |
| 102 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.58334040 |
| 103 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.58218109 |
| 104 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.57757988 |
| 105 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.57311991 |
| 106 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.56792902 |
| 107 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.56156626 |
| 108 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.55643097 |
| 109 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.55051869 |
| 110 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.54167086 |
| 111 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.54061759 |
| 112 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.53930727 |
| 113 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.53835075 |
| 114 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.53654618 |
| 115 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.53221156 |
| 116 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.53217984 |
| 117 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.52937797 |
| 118 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.52634860 |
| 119 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.52560514 |
| 120 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.52336612 |
| 121 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.52180351 |
| 122 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.51632608 |
| 123 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.51322912 |
| 124 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51040246 |
| 125 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.50859395 |
| 126 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.50777232 |
| 127 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.49978275 |
| 128 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.49311549 |
| 129 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.48443647 |
| 130 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.48131682 |
| 131 | * GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.47755651 |
| 132 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.47421460 |
| 133 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.47364063 |
| 134 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.46675881 |
| 135 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.46656032 |
| 136 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.46654788 |
| 137 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.46123218 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.14880974 |
| 2 | MP0005360_urolithiasis | 6.27553880 |
| 3 | MP0005365_abnormal_bile_salt | 5.48078396 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.34300747 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.93965265 |
| 6 | * MP0010329_abnormal_lipoprotein_level | 3.56371636 |
| 7 | MP0003252_abnormal_bile_duct | 3.42421094 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.41909817 |
| 9 | MP0009840_abnormal_foam_cell | 2.96073679 |
| 10 | MP0005083_abnormal_biliary_tract | 2.78162308 |
| 11 | MP0005670_abnormal_white_adipose | 2.75008572 |
| 12 | MP0005332_abnormal_amino_acid | 2.56377444 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 2.52274003 |
| 14 | MP0004130_abnormal_muscle_cell | 2.50288994 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.40097533 |
| 16 | * MP0002118_abnormal_lipid_homeostasis | 2.32632528 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.19807925 |
| 18 | * MP0000609_abnormal_liver_physiology | 2.07051944 |
| 19 | MP0003195_calcinosis | 2.05905097 |
| 20 | MP0005666_abnormal_adipose_tissue | 1.96244946 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 1.85138530 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.75276616 |
| 23 | MP0004272_abnormal_basement_membrane | 1.71404624 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 1.69070298 |
| 25 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59599879 |
| 26 | MP0002971_abnormal_brown_adipose | 1.53489220 |
| 27 | MP0003646_muscle_fatigue | 1.46160169 |
| 28 | * MP0005452_abnormal_adipose_tissue | 1.43806086 |
| 29 | MP0003868_abnormal_feces_composition | 1.40111310 |
| 30 | MP0003828_pulmonary_edema | 1.39857826 |
| 31 | MP0004185_abnormal_adipocyte_glucose | 1.38489870 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.32920580 |
| 33 | MP0003011_delayed_dark_adaptation | 1.30395447 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.27153956 |
| 35 | MP0005375_adipose_tissue_phenotype | 1.22542086 |
| 36 | MP0005503_abnormal_tendon_morphology | 1.20839433 |
| 37 | MP0003690_abnormal_glial_cell | 1.18821621 |
| 38 | MP0002254_reproductive_system_inflammat | 1.18112782 |
| 39 | MP0001764_abnormal_homeostasis | 1.17575113 |
| 40 | MP0005647_abnormal_sex_gland | 1.17528756 |
| 41 | MP0009643_abnormal_urine_homeostasis | 1.17104057 |
| 42 | MP0006036_abnormal_mitochondrial_physio | 1.15501881 |
| 43 | MP0001661_extended_life_span | 1.14702527 |
| 44 | * MP0005334_abnormal_fat_pad | 1.14206757 |
| 45 | MP0000604_amyloidosis | 1.13824246 |
| 46 | MP0000751_myopathy | 1.12766945 |
| 47 | MP0005330_cardiomyopathy | 1.07109542 |
| 48 | MP0005535_abnormal_body_temperature | 1.05359421 |
| 49 | * MP0002078_abnormal_glucose_homeostasis | 1.05131265 |
| 50 | MP0008438_abnormal_cutaneous_collagen | 1.03995814 |
| 51 | MP0010368_abnormal_lymphatic_system | 1.03811293 |
| 52 | MP0003186_abnormal_redox_activity | 1.03576500 |
| 53 | MP0003329_amyloid_beta_deposits | 1.00597341 |
| 54 | MP0002638_abnormal_pupillary_reflex | 0.97571026 |
| 55 | MP0001881_abnormal_mammary_gland | 0.97465491 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 0.95429588 |
| 57 | * MP0000598_abnormal_liver_morphology | 0.95356883 |
| 58 | MP0004036_abnormal_muscle_relaxation | 0.95133383 |
| 59 | MP0005451_abnormal_body_composition | 0.94761981 |
| 60 | MP0005379_endocrine/exocrine_gland_phen | 0.93036196 |
| 61 | MP0009115_abnormal_fat_cell | 0.93029788 |
| 62 | MP0002108_abnormal_muscle_morphology | 0.92416493 |
| 63 | MP0002269_muscular_atrophy | 0.90740587 |
| 64 | MP0003948_abnormal_gas_homeostasis | 0.89538940 |
| 65 | MP0004215_abnormal_myocardial_fiber | 0.89314754 |
| 66 | MP0004087_abnormal_muscle_fiber | 0.87288207 |
| 67 | MP0009697_abnormal_copulation | 0.86178604 |
| 68 | MP0005164_abnormal_response_to | 0.84055569 |
| 69 | MP0000343_altered_response_to | 0.81948911 |
| 70 | MP0002876_abnormal_thyroid_physiology | 0.81649234 |
| 71 | MP0005448_abnormal_energy_balance | 0.81636551 |
| 72 | MP0009763_increased_sensitivity_to | 0.80697419 |
| 73 | MP0004084_abnormal_cardiac_muscle | 0.77857706 |
| 74 | * MP0009642_abnormal_blood_homeostasis | 0.74623331 |
| 75 | MP0002970_abnormal_white_adipose | 0.74380864 |
| 76 | MP0000759_abnormal_skeletal_muscle | 0.74225282 |
| 77 | MP0009780_abnormal_chondrocyte_physiolo | 0.73680183 |
| 78 | MP0009764_decreased_sensitivity_to | 0.73272398 |
| 79 | MP0000749_muscle_degeneration | 0.73249426 |
| 80 | MP0006138_congestive_heart_failure | 0.72331743 |
| 81 | MP0005620_abnormal_muscle_contractility | 0.71096535 |
| 82 | MP0005266_abnormal_metabolism | 0.69736939 |
| 83 | MP0001544_abnormal_cardiovascular_syste | 0.68896685 |
| 84 | MP0005385_cardiovascular_system_phenoty | 0.68896685 |
| 85 | MP0001756_abnormal_urination | 0.67347307 |
| 86 | MP0000249_abnormal_blood_vessel | 0.67174370 |
| 87 | MP0005595_abnormal_vascular_smooth | 0.67107981 |
| 88 | MP0009384_cardiac_valve_regurgitation | 0.66218155 |
| 89 | MP0005376_homeostasis/metabolism_phenot | 0.66201755 |
| 90 | MP0005275_abnormal_skin_tensile | 0.65498563 |
| 91 | MP0006035_abnormal_mitochondrial_morpho | 0.64065236 |
| 92 | MP0000747_muscle_weakness | 0.63421060 |
| 93 | MP0000013_abnormal_adipose_tissue | 0.63398136 |
| 94 | MP0005636_abnormal_mineral_homeostasis | 0.63078327 |
| 95 | MP0001177_atelectasis | 0.62873988 |
| 96 | MP0000003_abnormal_adipose_tissue | 0.62849894 |
| 97 | MP0008775_abnormal_heart_ventricle | 0.61926695 |
| 98 | MP0010630_abnormal_cardiac_muscle | 0.61797652 |
| 99 | MP0004782_abnormal_surfactant_physiolog | 0.61273421 |
| 100 | MP0002295_abnormal_pulmonary_circulatio | 0.60818071 |
| 101 | MP0002972_abnormal_cardiac_muscle | 0.60045643 |
| 102 | MP0001879_abnormal_lymphatic_vessel | 0.58328292 |
| 103 | MP0000767_abnormal_smooth_muscle | 0.57161055 |
| 104 | MP0003566_abnormal_cell_adhesion | 0.56650889 |
| 105 | MP0000230_abnormal_systemic_arterial | 0.54968605 |
| 106 | MP0003279_aneurysm | 0.54792703 |
| 107 | * MP0003953_abnormal_hormone_level | 0.54380013 |
| 108 | MP0002909_abnormal_adrenal_gland | 0.54274688 |
| 109 | MP0001915_intracranial_hemorrhage | 0.53903177 |
| 110 | MP0002168_other_aberrant_phenotype | 0.53826959 |
| 111 | MP0008961_abnormal_basal_metabolism | 0.53529574 |
| 112 | MP0003075_altered_response_to | 0.53040485 |
| 113 | MP0002332_abnormal_exercise_endurance | 0.52913050 |
| 114 | MP0008469_abnormal_protein_level | 0.52889743 |
| 115 | MP0002796_impaired_skin_barrier | 0.52052245 |
| 116 | MP0003300_gastrointestinal_ulcer | 0.50281409 |
| 117 | MP0005167_abnormal_blood-brain_barrier | 0.50121062 |
| 118 | MP0001944_abnormal_pancreas_morphology | 0.49599876 |
| 119 | MP0001727_abnormal_embryo_implantation | 0.49325171 |
| 120 | MP0003724_increased_susceptibility_to | 0.48954869 |
| 121 | MP0002090_abnormal_vision | 0.47490009 |
| 122 | MP0009672_abnormal_birth_weight | 0.47227520 |
| 123 | MP0000639_abnormal_adrenal_gland | 0.46262698 |
| 124 | MP0005220_abnormal_exocrine_pancreas | 0.45987343 |
| 125 | MP0003959_abnormal_lean_body | 0.45938093 |
| 126 | MP0009703_decreased_birth_body | 0.45303163 |
| 127 | MP0008874_decreased_physiological_sensi | 0.44761141 |
| 128 | MP0003879_abnormal_hair_cell | 0.44382506 |
| 129 | MP0006276_abnormal_autonomic_nervous | 0.43647744 |
| 130 | MP0002128_abnormal_blood_circulation | 0.43425243 |
| 131 | MP0005388_respiratory_system_phenotype | 0.39920142 |
| 132 | MP0002133_abnormal_respiratory_system | 0.39920142 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.16407191 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.88368013 |
| 3 | Xanthomatosis (HP:0000991) | 5.69374559 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.38407822 |
| 5 | Hyperlipoproteinemia (HP:0010980) | 4.93328800 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.93137467 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 4.87573423 |
| 8 | Hyperglycinuria (HP:0003108) | 4.77247182 |
| 9 | Complement deficiency (HP:0004431) | 4.72745084 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 4.71454205 |
| 11 | Hyperammonemia (HP:0001987) | 4.62838465 |
| 12 | Ketosis (HP:0001946) | 4.60190584 |
| 13 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.51439288 |
| 14 | Abnormality of glycine metabolism (HP:0010895) | 4.51439288 |
| 15 | Hypoglycemic coma (HP:0001325) | 4.49898681 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 4.47648739 |
| 17 | Hyperglycinemia (HP:0002154) | 4.42101022 |
| 18 | Hypolipoproteinemia (HP:0010981) | 4.39878157 |
| 19 | Epidermoid cyst (HP:0200040) | 4.30184855 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.07790989 |
| 21 | Increased serum pyruvate (HP:0003542) | 4.00790971 |
| 22 | Ketoacidosis (HP:0001993) | 3.92788547 |
| 23 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.85925327 |
| 24 | Protrusio acetabuli (HP:0003179) | 3.85298387 |
| 25 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.62465520 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.61243830 |
| 27 | Abnormality of glycolysis (HP:0004366) | 3.49615031 |
| 28 | Abnormality of the common coagulation pathway (HP:0010990) | 3.45718072 |
| 29 | Joint hemorrhage (HP:0005261) | 3.40853555 |
| 30 | Glomerulonephritis (HP:0000099) | 3.38826070 |
| 31 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.35214656 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.31902927 |
| 33 | Abnormality of complement system (HP:0005339) | 3.29638124 |
| 34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.27707251 |
| 35 | Insulin resistance (HP:0000855) | 3.25988035 |
| 36 | Myoglobinuria (HP:0002913) | 3.17449422 |
| 37 | Abnormality of methionine metabolism (HP:0010901) | 3.15601233 |
| 38 | Increased variability in muscle fiber diameter (HP:0003557) | 3.11037212 |
| 39 | Fat malabsorption (HP:0002630) | 3.10406197 |
| 40 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.04510265 |
| 41 | Dicarboxylic aciduria (HP:0003215) | 3.04510265 |
| 42 | Difficulty running (HP:0009046) | 3.00766239 |
| 43 | Skin nodule (HP:0200036) | 3.00508841 |
| 44 | Abnormality of the intrinsic pathway (HP:0010989) | 2.94000740 |
| 45 | Abnormality of serum amino acid levels (HP:0003112) | 2.87729353 |
| 46 | Abnormality of alanine metabolism (HP:0010916) | 2.84849836 |
| 47 | Hyperalaninemia (HP:0003348) | 2.84849836 |
| 48 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.84849836 |
| 49 | Myocardial infarction (HP:0001658) | 2.83230947 |
| 50 | Hyperbilirubinemia (HP:0002904) | 2.75160550 |
| 51 | Metabolic acidosis (HP:0001942) | 2.72796104 |
| 52 | Delayed CNS myelination (HP:0002188) | 2.68263837 |
| 53 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.67256953 |
| 54 | Vertebral compression fractures (HP:0002953) | 2.65314906 |
| 55 | Abnormality of purine metabolism (HP:0004352) | 2.64714023 |
| 56 | Conjugated hyperbilirubinemia (HP:0002908) | 2.61639258 |
| 57 | Hypoglycemic seizures (HP:0002173) | 2.61374355 |
| 58 | Pigmentary retinal degeneration (HP:0001146) | 2.57943507 |
| 59 | Gout (HP:0001997) | 2.55298955 |
| 60 | Hepatocellular carcinoma (HP:0001402) | 2.53731717 |
| 61 | Potter facies (HP:0002009) | 2.53673367 |
| 62 | Facial shape deformation (HP:0011334) | 2.53673367 |
| 63 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.49785405 |
| 64 | Abnormality of nucleobase metabolism (HP:0010932) | 2.49628176 |
| 65 | Cholelithiasis (HP:0001081) | 2.49573735 |
| 66 | Abnormal gallbladder morphology (HP:0012437) | 2.48280491 |
| 67 | Exercise-induced myalgia (HP:0003738) | 2.42338082 |
| 68 | Lethargy (HP:0001254) | 2.42246816 |
| 69 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.38333564 |
| 70 | Hypertriglyceridemia (HP:0002155) | 2.36752759 |
| 71 | Growth hormone excess (HP:0000845) | 2.33872312 |
| 72 | Nephritis (HP:0000123) | 2.32435009 |
| 73 | Rickets (HP:0002748) | 2.32149577 |
| 74 | Rhabdomyolysis (HP:0003201) | 2.31601724 |
| 75 | Long foot (HP:0001833) | 2.29765703 |
| 76 | Mitral stenosis (HP:0001718) | 2.26124269 |
| 77 | Abnormality of proline metabolism (HP:0010907) | 2.25014511 |
| 78 | Hydroxyprolinuria (HP:0003080) | 2.25014511 |
| 79 | Cerebral edema (HP:0002181) | 2.23591481 |
| 80 | Late onset (HP:0003584) | 2.23050818 |
| 81 | Spastic diplegia (HP:0001264) | 2.19872187 |
| 82 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.19456482 |
| 83 | Sensorimotor neuropathy (HP:0007141) | 2.19209912 |
| 84 | Hyperglycemia (HP:0003074) | 2.18208971 |
| 85 | Subcapsular cataract (HP:0000523) | 2.18127804 |
| 86 | Infantile muscular hypotonia (HP:0008947) | 2.17183762 |
| 87 | Steatorrhea (HP:0002570) | 2.15609174 |
| 88 | Acanthocytosis (HP:0001927) | 2.14395005 |
| 89 | Generalized aminoaciduria (HP:0002909) | 2.13444258 |
| 90 | Esophageal varix (HP:0002040) | 2.10918457 |
| 91 | Abnormal gallbladder physiology (HP:0012438) | 2.09506232 |
| 92 | Cholecystitis (HP:0001082) | 2.09506232 |
| 93 | Abnormal cartilage morphology (HP:0002763) | 2.08833307 |
| 94 | Hemorrhage of the eye (HP:0011885) | 2.08082137 |
| 95 | Vomiting (HP:0002013) | 2.05253134 |
| 96 | Systemic lupus erythematosus (HP:0002725) | 2.04807807 |
| 97 | Increased muscle lipid content (HP:0009058) | 2.04665234 |
| 98 | Ectopia lentis (HP:0001083) | 2.04228915 |
| 99 | Abnormality of carpal bone ossification (HP:0006257) | 2.04067231 |
| 100 | Hypochromic microcytic anemia (HP:0004840) | 2.03456048 |
| 101 | Vascular calcification (HP:0004934) | 2.03024112 |
| 102 | Right ventricular cardiomyopathy (HP:0011663) | 2.03008639 |
| 103 | Neonatal onset (HP:0003623) | 2.02895659 |
| 104 | Premature rupture of membranes (HP:0001788) | 2.02294029 |
| 105 | Increased mean platelet volume (HP:0011877) | 2.01306179 |
| 106 | Hypophosphatemic rickets (HP:0004912) | 2.00709931 |
| 107 | Hyperuricemia (HP:0002149) | 1.98609353 |
| 108 | Increased purine levels (HP:0004368) | 1.98609353 |
| 109 | Prominent supraorbital ridges (HP:0000336) | 1.98585882 |
| 110 | Spontaneous abortion (HP:0005268) | 1.98239711 |
| 111 | Pancreatitis (HP:0001733) | 1.98013404 |
| 112 | Oligomenorrhea (HP:0000876) | 1.92538669 |
| 113 | Amyloidosis (HP:0011034) | 1.92418651 |
| 114 | Cardiovascular calcification (HP:0011915) | 1.91747572 |
| 115 | Hyporeflexia of lower limbs (HP:0002600) | 1.91584140 |
| 116 | Exercise-induced muscle cramps (HP:0003710) | 1.90032197 |
| 117 | Abnormality of the gallbladder (HP:0005264) | 1.89161844 |
| 118 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.87817171 |
| 119 | Lymphangioma (HP:0100764) | 1.85042435 |
| 120 | Renal cortical cysts (HP:0000803) | 1.84504634 |
| 121 | Turricephaly (HP:0000262) | 1.84347877 |
| 122 | Irritability (HP:0000737) | 1.84195517 |
| 123 | Spinal rigidity (HP:0003306) | 1.83086041 |
| 124 | Acanthosis nigricans (HP:0000956) | 1.83048008 |
| 125 | Coronal craniosynostosis (HP:0004440) | 1.82792963 |
| 126 | Back pain (HP:0003418) | 1.82157150 |
| 127 | Polycythemia (HP:0001901) | 1.82018092 |
| 128 | Abnormal hemoglobin (HP:0011902) | 1.81957095 |
| 129 | Atrioventricular block (HP:0001678) | 1.81950469 |
| 130 | Brushfield spots (HP:0001088) | 1.81800771 |
| 131 | Accelerated skeletal maturation (HP:0005616) | 1.81597925 |
| 132 | Vascular tortuosity (HP:0004948) | 1.81144030 |
| 133 | Malnutrition (HP:0004395) | 1.80672321 |
| 134 | Proximal tubulopathy (HP:0000114) | 1.79229153 |
| 135 | Aortic aneurysm (HP:0004942) | 1.77618865 |
| 136 | Bone cyst (HP:0012062) | 1.77426359 |
| 137 | Striae distensae (HP:0001065) | 1.77393269 |
| 138 | Enlarged kidneys (HP:0000105) | 1.75901058 |
| 139 | Abnormality of the lower motor neuron (HP:0002366) | 1.75303521 |
| 140 | Sudden death (HP:0001699) | 1.74762147 |
| 141 | Nausea (HP:0002018) | 1.74710585 |
| 142 | Tetraparesis (HP:0002273) | 1.74209711 |
| 143 | Axonal loss (HP:0003447) | 1.72734204 |
| 144 | Hypercortisolism (HP:0001578) | 1.69590786 |
| 145 | Abnormal delivery (HP:0001787) | 1.69118046 |
| 146 | Abnormal eating behavior (HP:0100738) | 1.68752105 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.23442436 |
| 2 | SIK1 | 4.48792777 |
| 3 | TRIB3 | 4.08214904 |
| 4 | EPHB2 | 3.10125703 |
| 5 | LMTK2 | 2.85332864 |
| 6 | ERN1 | 2.80898676 |
| 7 | PKN2 | 2.80679375 |
| 8 | FGFR4 | 2.65797500 |
| 9 | CAMK1D | 2.65072796 |
| 10 | INSRR | 2.34781885 |
| 11 | PDK3 | 2.18022197 |
| 12 | PDK4 | 2.18022197 |
| 13 | TTN | 2.10942758 |
| 14 | PHKG2 | 2.04275234 |
| 15 | PHKG1 | 2.04275234 |
| 16 | CAMK1G | 1.94824254 |
| 17 | CAMK1 | 1.93986671 |
| 18 | RIPK1 | 1.91723893 |
| 19 | FGFR2 | 1.89121335 |
| 20 | LATS1 | 1.73751422 |
| 21 | MAP3K6 | 1.66333987 |
| 22 | OBSCN | 1.59058623 |
| 23 | MST1R | 1.49984660 |
| 24 | PINK1 | 1.45944450 |
| 25 | MAP2K4 | 1.45358573 |
| 26 | CAMKK2 | 1.43819004 |
| 27 | PRKAA2 | 1.43589423 |
| 28 | MAP3K7 | 1.42466837 |
| 29 | MAP3K10 | 1.41871999 |
| 30 | NLK | 1.35595548 |
| 31 | PTK6 | 1.27816493 |
| 32 | TESK1 | 1.27712326 |
| 33 | MAPK11 | 1.24246715 |
| 34 | AKT3 | 1.22213251 |
| 35 | PIK3CG | 1.19314605 |
| 36 | FRK | 1.18355837 |
| 37 | PDK2 | 1.17418915 |
| 38 | DAPK2 | 1.15861924 |
| 39 | ERBB4 | 1.15058563 |
| 40 | PDGFRA | 1.10525978 |
| 41 | FLT3 | 1.10287505 |
| 42 | PRKAA1 | 1.09969889 |
| 43 | MAPK12 | 1.02647504 |
| 44 | PIK3CA | 1.02501216 |
| 45 | TIE1 | 1.02217380 |
| 46 | FGFR3 | 1.00480563 |
| 47 | CDK9 | 0.94044296 |
| 48 | TAOK3 | 0.93931341 |
| 49 | NEK9 | 0.93575304 |
| 50 | JAK1 | 0.93538463 |
| 51 | SGK3 | 0.87889466 |
| 52 | JAK2 | 0.86786309 |
| 53 | PAK2 | 0.86547734 |
| 54 | TYRO3 | 0.86495857 |
| 55 | PRPF4B | 0.86355200 |
| 56 | SCYL2 | 0.85693279 |
| 57 | EPHB1 | 0.79623767 |
| 58 | RET | 0.79188386 |
| 59 | NEK1 | 0.78309136 |
| 60 | PTK2 | 0.75185009 |
| 61 | MAP2K3 | 0.74721679 |
| 62 | PDPK1 | 0.73978490 |
| 63 | PRKACG | 0.71273004 |
| 64 | PAK3 | 0.70964845 |
| 65 | EPHA4 | 0.70523221 |
| 66 | ICK | 0.70147230 |
| 67 | MET | 0.68544931 |
| 68 | MYLK | 0.68489309 |
| 69 | PRKD1 | 0.67624575 |
| 70 | CDK6 | 0.67600776 |
| 71 | TGFBR2 | 0.67348868 |
| 72 | NTRK1 | 0.67251220 |
| 73 | PRKG1 | 0.66192945 |
| 74 | MAP2K1 | 0.63295577 |
| 75 | TYK2 | 0.62819752 |
| 76 | ARAF | 0.60298568 |
| 77 | MTOR | 0.60168982 |
| 78 | AKT2 | 0.59385653 |
| 79 | STK38L | 0.58235892 |
| 80 | YES1 | 0.56755491 |
| 81 | PDK1 | 0.56046771 |
| 82 | SGK2 | 0.54912525 |
| 83 | MAPK3 | 0.54718070 |
| 84 | ERBB2 | 0.54416320 |
| 85 | PRKCH | 0.54137889 |
| 86 | MAPK4 | 0.53730408 |
| 87 | PRKACB | 0.53081808 |
| 88 | LATS2 | 0.52310124 |
| 89 | ABL2 | 0.51633210 |
| 90 | PRKCZ | 0.51229214 |
| 91 | KSR2 | 0.50293482 |
| 92 | STK38 | 0.49979454 |
| 93 | GSK3A | 0.48834946 |
| 94 | SGK223 | 0.47738956 |
| 95 | SGK494 | 0.47738956 |
| 96 | KDR | 0.46221146 |
| 97 | FGFR1 | 0.45184825 |
| 98 | NTRK3 | 0.44488276 |
| 99 | STK3 | 0.44110754 |
| 100 | BMX | 0.43986870 |
| 101 | MOS | 0.43691175 |
| 102 | GRK5 | 0.42854453 |
| 103 | INSR | 0.42837141 |
| 104 | MAP3K3 | 0.42285378 |
| 105 | MAPKAPK3 | 0.41853576 |
| 106 | DDR2 | 0.41440256 |
| 107 | EPHA3 | 0.40680391 |
| 108 | DMPK | 0.40658981 |
| 109 | DYRK1B | 0.40163312 |
| 110 | EEF2K | 0.40134751 |
| 111 | GRK6 | 0.39806223 |
| 112 | FER | 0.39289172 |
| 113 | PRKACA | 0.38243298 |
| 114 | ROCK1 | 0.37518432 |
| 115 | MAPK7 | 0.37149529 |
| 116 | ERBB3 | 0.37026665 |
| 117 | IGF1R | 0.36775194 |
| 118 | CAMK4 | 0.36409427 |
| 119 | TRPM7 | 0.36388283 |
| 120 | PKN1 | 0.36156314 |
| 121 | CAMKK1 | 0.34877320 |
| 122 | ADRBK1 | 0.34840752 |
| 123 | PDGFRB | 0.34717206 |
| 124 | CAMK2G | 0.33129287 |
| 125 | CLK1 | 0.32750940 |
| 126 | MAP3K4 | 0.32267310 |
| 127 | MAPK1 | 0.30965774 |
| 128 | RPS6KA3 | 0.30804069 |
| 129 | ILK | 0.30056650 |
| 130 | LRRK2 | 0.30031815 |
| 131 | CDK4 | 0.29104880 |
| 132 | CSNK1E | 0.28285713 |
| 133 | CDK5 | 0.27519920 |
| 134 | PRKD3 | 0.27097762 |
| 135 | EIF2AK2 | 0.26332821 |
| 136 | PAK6 | 0.26226065 |
| 137 | SRC | 0.26110238 |
| 138 | MARK1 | 0.24920079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.85550096 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.70807227 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.13540845 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.05700149 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.90674073 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.88578025 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.75990053 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.75651405 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.72653732 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.67970740 |
| 11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.65381302 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.47412438 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.44478406 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.32111933 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.28635468 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.16698617 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.06263327 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.00996289 |
| 19 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.82770917 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.79939566 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.78524616 |
| 22 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.78354906 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.77697416 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.64568952 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.58081374 |
| 26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.57991921 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.57107188 |
| 28 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.52157860 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.50249416 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.45621659 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.45243198 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.42649899 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.41192157 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.36017342 |
| 35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.35427788 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.33852188 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31919122 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.30682946 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.29976621 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23836858 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.23069963 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.21702796 |
| 43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.21524041 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.18968594 |
| 45 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.18904644 |
| 46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.16671950 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.04844972 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.03285073 |
| 49 | Lysine degradation_Homo sapiens_hsa00310 | 1.01544114 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.98611837 |
| 51 | * Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.96952826 |
| 52 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.88300951 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.82914616 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.82798012 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81576236 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.75897559 |
| 57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75198133 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66753890 |
| 59 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.66400885 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.65866970 |
| 61 | Insulin resistance_Homo sapiens_hsa04931 | 0.65821940 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.64917984 |
| 63 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61699175 |
| 64 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.61464307 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58681722 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57793864 |
| 67 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.52078557 |
| 68 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.49984767 |
| 69 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.49454245 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.48889291 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.40069989 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.39451906 |
| 73 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36451443 |
| 74 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.34416901 |
| 75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29664378 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26399585 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.24744196 |
| 78 | Renin secretion_Homo sapiens_hsa04924 | 0.23942876 |
| 79 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.23618465 |
| 80 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21612895 |
| 81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21352070 |
| 82 | Focal adhesion_Homo sapiens_hsa04510 | 0.20443578 |
| 83 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.19802123 |
| 84 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.15214509 |
| 85 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.12988022 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.10145429 |
| 87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.09991769 |
| 88 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.09760793 |
| 89 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.08178207 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.07396431 |
| 91 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.06722308 |
| 92 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.05077366 |
| 93 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.03397906 |
| 94 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.00165630 |
| 95 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.1466698 |
| 96 | Cardiac muscle contraction_Homo sapiens_hsa04260 | -0.1311426 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | -0.1133006 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | -0.0982040 |
| 99 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0973146 |
| 100 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0823403 |
| 101 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0699539 |
| 102 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0570364 |
| 103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | -0.0480370 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0465607 |
| 105 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.0452606 |
| 106 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | -0.0426905 |
| 107 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.0414970 |
| 108 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | -0.0350735 |
| 109 | Proteoglycans in cancer_Homo sapiens_hsa05205 | -0.0268005 |
| 110 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0219368 |
| 111 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0185842 |
| 112 | Adherens junction_Homo sapiens_hsa04520 | -0.0083417 |
| 113 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0040525 |

